
TY  - JOUR
TI  - Poster Sessions Tuesday/Wednesday
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 125
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/jnc.12186
DO  - doi:10.1111/jnc.12186
SP  - 194
EP  - 280
PY  - 2013
ER  - 

TY  - JOUR
AU  - Loera-Valencia, R.
AU  - Cedazo-Minguez, A.
AU  - Kenigsberg, P.A.
AU  - Page, G.
AU  - Duarte, A.I.
AU  - Giusti, P.
AU  - Zusso, M.
AU  - Robert, P.
AU  - Frisoni, G. B.
AU  - Cattaneo, A.
AU  - Zille, M.
AU  - Boltze, J.
AU  - Cartier, N.
AU  - Buee, L.
AU  - Johansson, G.
AU  - Winblad, B.
TI  - Current and emerging avenues for Alzheimer's disease drug targets
JO  - Journal of Internal Medicine
JA  - J Intern Med
VL  - 286
IS  - 4
SN  - 0954-6820
UR  - https://doi.org/10.1111/joim.12959
DO  - doi:10.1111/joim.12959
SP  - 398
EP  - 437
KW  - AD gene therapy
KW  - AD molecular targets
KW  - AD therapeutics
KW  - alzheimer´s disease
KW  - amyloid beta therapies
KW  - Tau therapies
PY  - 2019
AB  - Abstract Alzheimer's disease (AD), the most frequent cause of dementia, is escalating as a global epidemic, and so far, there is neither cure nor treatment to alter its progression. The most important feature of the disease is neuronal death and loss of cognitive functions, caused probably from several pathological processes in the brain. The main neuropathological features of AD are widely described as amyloid beta (A?) plaques and neurofibrillary tangles of the aggregated protein tau, which contribute to the disease. Nevertheless, AD brains suffer from a variety of alterations in function, such as energy metabolism, inflammation and synaptic activity. The latest decades have seen an explosion of genes and molecules that can be employed as targets aiming to improve brain physiology, which can result in preventive strategies for AD. Moreover, therapeutics using these targets can help AD brains to sustain function during the development of AD pathology. Here, we review broadly recent information for potential targets that can modify AD through diverse pharmacological and nonpharmacological approaches including gene therapy. We propose that AD could be tackled not only using combination therapies including A? and tau, but also considering insulin and cholesterol metabolism, vascular function, synaptic plasticity, epigenetics, neurovascular junction and blood?brain barrier targets that have been studied recently. We also make a case for the role of gut microbiota in AD. Our hope is to promote the continuing research of diverse targets affecting AD and promote diverse targeting as a near-future strategy.
ER  - 

TY  - JOUR
TI  - Selected Abstracts from Pharmacology 2018
JO  - British Journal of Pharmacology
JA  - Br J Pharmacol
VL  - 176
IS  - 16
SN  - 0007-1188
UR  - https://doi.org/10.1111/bph.14681
DO  - doi:10.1111/bph.14681
SP  - 2977
EP  - 3081
PY  - 2019
ER  - 

TY  - JOUR
TI  - Short Paper Sessions
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 8
IS  - 1
SN  - 0148-6071
UR  - https://doi.org/10.1177/014860718400800121
DO  - doi:10.1177/014860718400800121
SP  - 84
EP  - 103
PY  - 1984
ER  - 

AU  - Beeching, Nicholas J.
AU  - Welby, Sharon B.
C7  - pp. 185-209
TI  - Returned Travellers
SN  - 9780471490791
UR  - https://doi.org/10.1002/0470842512.ch12
DO  - doi:10.1002/0470842512.ch12
SP  - 185-209
KW  - returned travellers
KW  - fever
KW  - malaria
KW  - dengue fever
KW  - respiratory illness
KW  - STD
KW  - HIV
KW  - parasites
PY  - 1984
AB  - Summary The approach to the diagnosis and management of travel-related disease, particularly infections acquired in less-developed countries, is described using key decision points with case examples and illustrative tables and algorithms. A detailed travel history is essential including prophylactic immunisations, antimalarial drugs, underlying illness, appropriate sexual history, mode of travel and places visited. It is essential to consider and exclude or treat malaria and other causes of fever (including dengue fever which is now widespread throughout Asia, South and Central America and the Caribbean, and is spreading throughout Africa), respiratory infections (of which Streptococcal pneumonia which is multiresistant in many countries and Legionella are of particular importance), and persistent travel-related diarrhoea which requires investigation among others. The risk of HIV must not be omitted. Eosinophilia usually suggests parasitic infections particularly schistosomiasis, filariasis and intestinal nematode infections such as hookworm, trichuriasis and strongyloidiasis. Skin diseases are common in returned travellers. In some groups of travellers, post-travel health screening may be appropriate.
ER  - 

TY  - JOUR
C7  - e12328
TI  - IXA 2017- Abstracts of the 14th Congress of the International Xenotransplantation Association, Baltimore, USA
JO  - Xenotransplantation
JA  - Xenotransplantation
VL  - 24
IS  - 5
SN  - 9780471490791
UR  - https://doi.org/10.1111/xen.12328
DO  - doi:10.1111/xen.12328
SP  - e12328
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts 1 - 543
JO  - American Journal of Transplantation
VL  - 4
IS  - s8
SN  - 9780471490791
UR  - https://doi.org/10.1111/j.1600-6135.2004.0480a.x
DO  - doi:10.1111/j.1600-6135.2004.0480a.x
SP  - 160
EP  - 307
PY  - 2004
ER  - 

C7  - pp. 1-486
TI  - English to Spanish
SN  - 9781118237977
UR  - https://doi.org/10.1002/9781118797907.ch1
DO  - doi:10.1002/9781118797907.ch1
SP  - 1-486
KW  - Absolute accuracy
KW  - Absorbance
KW  - Absorption paper
KW  - Abundance ratio
KW  - Acclimatisation
KW  - Backdonation
KW  - Backextraction
KW  - Balanced reaction
KW  - Barff process
KW  - Barium acetate
KW  - Carbon
KW  - Cacao butter
KW  - Cacodylic acid
KW  - Cadmium acetate
KW  - Cacodyl chloride
KW  - Dactinomycin
KW  - Dahllite
KW  - Dahmenite
KW  - Dark resistance
KW  - Darmstadtium
KW  - E-book
KW  - E-mail
KW  - Ecgonine
KW  - Eclogite
KW  - Eclampsia
KW  - Fabianol
KW  - Face-centered cubic
KW  - Factor analysis
KW  - Fahrenheit degree
KW  - False positive
KW  - Gabriel reaction
KW  - Gadoleic acid
KW  - Gadolinium bromide
KW  - Galactorrhea
KW  - Galenite
KW  - Haemochrome
KW  - Haemophilia
KW  - Hafnium disulphide
KW  - Halogenating agent
KW  - Hamiltonian mechanics
KW  - Iatrogenic disease
KW  - Iceland moss
KW  - Ichthyocolla
KW  - Icosahedron
KW  - Identity period
KW  - Jacobsen rearrangement
KW  - Janovsky reaction
KW  - Jasmine oil
KW  - Jasmone
KW  - Jeweller's rogue
KW  - Kairomone
KW  - Kappa receptor
KW  - Kava kava
KW  - Keesom relationship
KW  - Kelvin effect
KW  - Lab apparatus
KW  - Lab coat
KW  - Labyrinth
KW  - Labradorite
KW  - Lycopodium
KW  - Macrobiotic diet
KW  - Magnesium bromide
KW  - Maintenance medications
KW  - Magnetisability
KW  - Magnetoencephalograph
KW  - Nalorphine
KW  - Nano-electronics
KW  - Naphthyl alcohol
KW  - Natrolite
KW  - Natural alloy
KW  - Obermayer reagent
KW  - Occlusion
KW  - Ohm's law
KW  - Olfactory cells
KW  - Olfactory stimulation
KW  - Palate
KW  - Palindrome
KW  - Pamoic acid
KW  - Palmitolic acid
KW  - Palmitoyl chloride
KW  - Quadruple resonance
KW  - Qualitative analysis
KW  - Quantitative inheritance
KW  - Quantitative reaction
KW  - Quantum equivalence
KW  - Racemic acid
KW  - Radiation absorber
KW  - Radiation effect
KW  - Radiation hazard
KW  - Radio-carbon
KW  - Radiative capture
KW  - Sabinol
KW  - Saccharase
KW  - Saccharification
KW  - Sacrificial donor
KW  - Safranine
KW  - Tachiol taconite
KW  - Tacrine
KW  - Tactic polymer
KW  - Tactosol
KW  - Ullman reaction
KW  - Ulmin ulcer
KW  - Ultiva
KW  - Ultraviolet radiation
KW  - Vaccination
KW  - Vacuum crystalliser
KW  - Valence transition
KW  - Valeraldehyde
KW  - Valerian oil
KW  - Wacker reaction
KW  - Wagnerite
KW  - Warfarin
KW  - Water sterilisation
KW  - Water still
KW  - X chromosome
KW  - X-ray analysis
KW  - Xenol
KW  - Xenon
KW  - Xenylamine
KW  - Y chromosome yacca gum
KW  - Yttrium nitrate
KW  - Yttrium oxide
KW  - Yttrotantalite
KW  - Zaleplon
KW  - Zaratite
KW  - Zeaxanthin
KW  - Zeeman effect
KW  - Zeise sait
PY  - 2004
AB  - Summary This chapter contains sections titled: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Greek Letters
ER  - 

TY  - JOUR
TI  - Poster Abstracts II
JO  - Journal of Gastroenterology and Hepatology
VL  - 25
IS  - s2
SN  - 9781118237977
UR  - https://doi.org/10.1111/j.1440-1746.2009.06464.x
DO  - doi:10.1111/j.1440-1746.2009.06464.x
SP  - A79
EP  - A176
PY  - 2010
ER  - 

C7  - pp. 221-387
TI  - Organ Toxicology
UR  - https://doi.org/10.1002/9781119135944.ch3
DO  - doi:10.1002/9781119135944.ch3
SP  - 221-387
KW  - behavioral neurotoxicology
KW  - endocrine system
KW  - gastrointestinal tract
KW  - immune system
KW  - organ toxicology
KW  - respiratory system
KW  - skin cells
KW  - urinary tract
PY  - 2010
AB  - Summary This chapter focuses on the normal sequence of events in marrow function, the roles played by circulating cells in homeostasis, and on the adverse effects caused by exposure to various drugs and other chemicals leading to commonly observed hemopathies. The hair follicle's proliferative activity is matched only by the bone marrow and some parts of the gastrointestinal tract. In contrast to the skin, the respiratory tract has no barrier, other than the bronchial mucous layer, against the entry of foreign substances into the body. The chapter also focuses on the parts of the endocrine system relating to thyroid and sex hormones in humans and laboratory animals that are of interest to toxicology. Clinical experience with immunosuppressive drugs indicates that the immune system usually has a high capacity to regenerate after exposure has ended.
ER  - 

TY  - JOUR
TI  - Australasian College of Dermatologists Abstracts Presented at the 52nd Annual Scientific Meeting 18–21 May 2019 Melbourne Convention and Exhibition Centre Melbourne, Victoria
JO  - Australasian Journal of Dermatology
JA  - Australas J Dermatol
VL  - 60
IS  - S1
UR  - https://doi.org/10.1111/ajd.13027
DO  - doi:10.1111/ajd.13027
SP  - 14
EP  - 106
PY  - 2019
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Respirology
VL  - 14
IS  - s3
UR  - https://doi.org/10.1111/j.1440-1843.2009.01657.x
DO  - doi:10.1111/j.1440-1843.2009.01657.x
SP  - A125
EP  - A169
PY  - 2009
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 39
IS  - S1
UR  - https://doi.org/10.1002/eji.200990224
DO  - doi:10.1002/eji.200990224
SP  - S55
EP  - S279
PY  - 2009
AB  - Abstract No Abtract
ER  - 

TY  - JOUR
TI  - 2015 ACVIM Forum Research Abstract Program
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 29
IS  - 4
UR  - https://doi.org/10.1111/jvim.12609
DO  - doi:10.1111/jvim.12609
SP  - 1122
EP  - 1256
PY  - 2015
ER  - 

TY  - JOUR
TI  - XXII International Pigment Cell Conference (IPCC) “Bringing Colors to Life: Advances in Pigment Cell Research and Translation into Clinical Practice” Organised by the Asian Society for Pigment Cell Research (ASPCR), in partnership with the Dermatological Society of Singapore (DSS)
JO  - Pigment Cell & Melanoma Research
JA  - Pigment Cell Melanoma Res.
VL  - 27
IS  - 5
UR  - https://doi.org/10.1111/pcmr.12292
DO  - doi:10.1111/pcmr.12292
SP  - 849
EP  - 1001
PY  - 2014
ER  - 

TY  - JOUR
TI  - American Association of Anatomists. Seventy-Eighth Annual Session. University of Miami School of Medicine, April 20, 21, 22, 23, 1965. Officers, abstracts, demonstrations
JO  - The Anatomical Record
JA  - Anat. Rec.
VL  - 151
IS  - 3
UR  - https://doi.org/10.1002/ar.1091510312
DO  - doi:10.1002/ar.1091510312
SP  - 315
EP  - 501
PY  - 1965
ER  - 

TY  - JOUR
TI  - Abstracts and Index of Authors
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
JA  - Pharmacotherapy
VL  - 32
IS  - 10
UR  - https://doi.org/10.1002/j.1875-9114.2012.01219
DO  - doi:10.1002/j.1875-9114.2012.01219
SP  - e178
EP  - e320
PY  - 2012
ER  - 

TY  - JOUR
TI  - Subspecialty Poster Sessions
JO  - European Journal of Clinical Investigation
VL  - 41
IS  - s1
UR  - https://doi.org/10.1111/j.1365-2362.2011.02507.x
DO  - doi:10.1111/j.1365-2362.2011.02507.x
SP  - 3
EP  - 22
PY  - 2011
ER  - 

TY  - JOUR
AU  - Szczepiorkowski, Zbigniew M.
AU  - Winters, Jeffrey L.
AU  - Bandarenko, Nicholas
AU  - Kim, Haewon C.
AU  - Linenberger, Michael L.
AU  - Marques, Marisa B.
AU  - Sarode, Ravindra
AU  - Schwartz, Joseph
AU  - Weinstein, Robert
AU  - Shaz, Beth H.
TI  - Guidelines on the use of therapeutic apheresis in clinical practice—Evidence-based approach from the apheresis applications committee of the American Society for Apheresis
JO  - Journal of Clinical Apheresis
JA  - J. Clin. Apheresis
VL  - 25
IS  - 3
UR  - https://doi.org/10.1002/jca.20240
DO  - doi:10.1002/jca.20240
SP  - 83
EP  - 177
KW  - apheresis
KW  - plasma exchange
KW  - immunoadsorption
KW  - leukocytapheresis
KW  - photopheresis
KW  - categories
KW  - indications
KW  - evidence based
PY  - 2010
AB  - Abstract The American Society for Apheresis (ASFA) Apheresis Applications Committee is charged with a review and categorization of indications for therapeutic apheresis. Beginning with the 2007 ASFA Special Issue (fourth edition), the subcommittee has incorporated systematic review and evidence-based approach in the grading and categorization of indications. This Fifth ASFA Special Issue has further improved the process of using evidence-based medicine in the recommendations by refining the category definitions and by adding a grade of recommendation based on widely accepted GRADE system. The concept of a fact sheet was introduced in the Fourth edition and is only slightly modified in this current edition. The fact sheet succinctly summarizes the evidence for the use of therapeutic apheresis. The article consists of 59 fact sheets devoted to each disease entity currently categorized by the ASFA as category I through III. Category IV indications are also listed. J. Clin. Apheresis, 2010. ? 2010 American Society for Apheresis
ER  - 

TY  - JOUR
TI  - ASBMR 30th Annual Meeting SA001–SA572
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 23
IS  - S1
UR  - https://doi.org/10.1002/jbmr.5650231304
DO  - doi:10.1002/jbmr.5650231304
SP  - S136
EP  - S243
PY  - 2008
ER  - 
